Literature DB >> 21538670

Near real-time vaccine safety surveillance with partially accrued data.

Sharon K Greene1, Martin Kulldorff, Ruihua Yin, W Katherine Yih, Tracy A Lieu, Eric S Weintraub, Grace M Lee.   

Abstract

PURPOSE: The Vaccine Safety Datalink (VSD) Project conducts near real-time vaccine safety surveillance using sequential analytic methods. Timely surveillance is critical in identifying potential safety problems and preventing additional exposure before most vaccines are administered. For vaccines that are administered during a short period, such as influenza vaccines, timeliness can be improved by undertaking analyses while risk windows following vaccination are ongoing and by accommodating predictable and unpredictable data accrual delays. We describe practical solutions to these challenges, which were adopted by the VSD Project during pandemic and seasonal influenza vaccine safety surveillance in 2009/2010.
METHODS: Adjustments were made to two sequential analytic approaches. The Poisson-based approach compared the number of pre-defined adverse events observed following vaccination with the number expected using historical data. The expected number was adjusted for the proportion of the risk window elapsed and the proportion of inpatient data estimated to have accrued. The binomial-based approach used a self-controlled design, comparing the observed numbers of events in risk versus comparison windows. Events were included in analysis only if they occurred during a week that had already passed for both windows.
RESULTS: Analyzing data before risk windows fully elapsed improved the timeliness of safety surveillance. Adjustments for data accrual lags were tailored to each data source and avoided biasing analyses away from detecting a potential safety problem, particularly early during surveillance.
CONCLUSIONS: The timeliness of vaccine and drug safety surveillance can be improved by properly accounting for partially elapsed windows and data accrual delays.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21538670     DOI: 10.1002/pds.2133

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  11 in total

1.  Orphan therapies: making best use of postmarket data.

Authors:  Judith C Maro; Jeffrey S Brown; Gerald J Dal Pan; Lingling Li
Journal:  J Gen Intern Med       Date:  2014-08       Impact factor: 5.128

2.  Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine.

Authors:  James G Donahue; Burney A Kieke; Edwin M Lewis; Eric S Weintraub; Kayla E Hanson; David L McClure; Elizabeth R Vickers; Julianne Gee; Matthew F Daley; Frank DeStefano; Rulin C Hechter; Lisa A Jackson; Nicola P Klein; Allison L Naleway; Jennifer C Nelson; Edward A Belongia
Journal:  Pediatrics       Date:  2019-11-18       Impact factor: 7.124

3.  Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrual.

Authors:  Taliser R Avery; Martin Kulldorff; Yury Vilk; Lingling Li; T Craig Cheetham; Sascha Dublin; Robert L Davis; Liyan Liu; Lisa Herrinton; Jeffrey S Brown
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-02-12       Impact factor: 2.890

4.  Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity.

Authors:  Judith C Maro; Jeffrey S Brown; Gerald J Dal Pan; Martin Kulldorff
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-04-03       Impact factor: 2.890

5.  Assessing recording delays in general practice records to inform near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD).

Authors:  Andreia Leite; Nick J Andrews; Sara L Thomas
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-02-03       Impact factor: 2.890

6.  Development and application of two semi-automated tools for targeted medical product surveillance in a distributed data network.

Authors:  John G Connolly; Shirley V Wang; Candace C Fuller; Sengwee Toh; Catherine A Panozzo; Noelle Cocoros; Meijia Zhou; Joshua J Gagne; Judith C Maro
Journal:  Curr Epidemiol Rep       Date:  2017-10-06

7.  Visualizing the quality of partially accruing data for use in decision making.

Authors:  Julia Eaton; Ian Painter; Don Olson; William B Lober
Journal:  Online J Public Health Inform       Date:  2015-12-30

8.  A Synthesis of Current Surveillance Planning Methods for the Sequential Monitoring of Drug and Vaccine Adverse Effects Using Electronic Health Care Data.

Authors:  Jennifer C Nelson; Robert Wellman; Onchee Yu; Andrea J Cook; Judith C Maro; Rita Ouellet-Hellstrom; Denise Boudreau; James S Floyd; Susan R Heckbert; Simone Pinheiro; Marsha Reichman; Azadeh Shoaibi
Journal:  EGEMS (Wash DC)       Date:  2016-09-06

Review 9.  Near real-time vaccine safety surveillance using electronic health records-a systematic review of the application of statistical methods.

Authors:  Andreia Leite; Nick J Andrews; Sara L Thomas
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-01-28       Impact factor: 2.890

10.  Prospective influenza vaccine safety surveillance using fresh data in the Sentinel System.

Authors:  Weiling Katherine Yih; Martin Kulldorff; Sukhminder K Sandhu; Lauren Zichittella; Judith C Maro; David V Cole; Robert Jin; Alison Tse Kawai; Meghan A Baker; Chunfu Liu; Cheryl N McMahill-Walraven; Mano S Selvan; Richard Platt; Michael D Nguyen; Grace M Lee
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-11-17       Impact factor: 2.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.